Arun Danewa: Saving a Bone Marrow Patient from Hidden Enemy – TA-TMA
Arun Danewa, Senior Consultant at Artemis Hospitals, shared a post on LinkedIn:
“The Blood Vessel Mystery: Saving a Bone Marrow Patient
Think of a Bone Marrow Transplant (BMT) as a total system restart. It’s a lifesaving process, but sometimes the ‘new system’ hits a dangerous glitch.
In this case, a patient recovering from severe aplastic anemia survived a massive infection (MDR Sepsis) only to face a new, hidden enemy:
Transplant Associated Thrombotic microangiopathy (TA-TMA).
The Red Flags
How do you know when something is wrong?
The body starts sending ‘SOS’ signals.
For our patient, those signals were:
- High Blood Pressure: The heart was working too hard.
- Protein in Urine: A sign the kidneys were struggling.
- Crushed Red Cells: Under the microscope, we saw Schistocytes—red blood cells that looked like they’d been shattered.
These ‘alarm bells’ pointed to TA-TMA, a condition where tiny blood clots start forming in the small vessels, damaging organs.
The Rescue Plan
To fix this, we had to act like detectives and change our strategy fast:
- Stop the ‘Trigger’: We realized a specific medicine the patient was taking to prevent transplant rejection (Cyclosporine) was actually causing the damage. We stopped it immediately.
- Switch the Shield: To keep the patient safe from rejection, we switched them to Steroids instead.
- Double-Check the Enemy: We ran a special test (ADAMTS13) to make sure this wasn’t a different, rarer blood disorder. The test confirmed we were on the right track.
The Result: A Huge Comeback
In just 11 days, the patient’s body began to heal. The ‘stress’ markers in their blood dropped, and their healthy cell counts climbed back up.
The Lesson
In transplant medicine, watching closely saves lives. By catching high blood pressure and kidney changes early, we can stop a major complication before it does permanent damage. It’s all about knowing when to change the plan to fit the patient’s needs.”

Stay updated with Hemostasis Today.
-
Jul 7, 2026, 06:19Simone Schoenwaelder: Women Are 25% More Likely to Have Their Stroke Misdiagnosed and Here’s Why
-
Jul 7, 2026, 06:12Dhiraj Bhatia: Extremely Happy to Share Our Review on DNA Nanotechnology in Stroke Repair
-
Jul 7, 2026, 06:04Brian A Beh: An Open Letter to Lisa Murphy Honouring the 30 Years of the Stroke Foundation’s Dedication
-
Jul 7, 2026, 05:55Alan Nurden: A Landmark Review Comparing Hemophilia and Hereditary Angioedema
-
Jul 7, 2026, 05:40Andrew Agwunobi: UConn Health is Proud to Advance Stroke Rehabilitation for Veterans
-
Jul 6, 2026, 22:54Louise St. Germain Bannon: I Wanted to Recognize the Incredible Staff Behind ISTH 2026
-
Jul 6, 2026, 21:46Armghan Ans: UPMC Washington Stroke Program Earns AHA Gold Plus Award for 16th Consecutive Year
-
Jul 6, 2026, 20:31Manik Madaan: Master Transfusion Reactions for USMLE In Less Than 60 Seconds
-
Jul 6, 2026, 19:25Ambreen Kashif: Highlighting the Impact of Temporary Donor Deferrals on Donor Retention